Investigation of a Botulism Case following Illegal Medical Aesthetic Injections, Taiwan, 2025

DOI: 10.6524/EB.202610_42(20).0001

Hsiao-Chiao Hsu^*, Pei-Chen Chen, Wan-Lin Hsu, Yen-I Lee, Hsiao-Ping Tung, Shih-Hao Liu

2026 Vol.42 NO.20

Correspondence Author： Hsiao-Chiao Hsu^*

Abstract：

        In March 2025, the Taiwan Centers for Disease Control was notified by a hospital of a suspected case of iatrogenic botulism in a 40-year-old foreign woman. She had received cosmetic botulinum toxin injections at home, administered by an unlicensed individual using an unapproved product purchased online. Three days later, she developed dysphagia, dry mouth, ptosis, and muscle weakness. She was admitted to the intensive care unit, required mechanical ventilatory support, and was treated with botulinum antitoxin at her own expense. Her condition improved, and she was discharged in stable condition after three weeks of hospitalization.
        The public is advised to seek medical aesthetic treatments only at licensed medical institutions, ensure that providers are certified healthcare professionals, and verify that any injectable products are approved by regulatory authorities. Individuals who experience suspected botulism symptoms after injections should seek medical attention promptly and inform healthcare providers of their injection history to facilitate timely reporting and treatment.